共 205 条
- [1] Akiba J(2004)Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies Lancet 363 157-163
- [2] Nakashima O(2013)Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification Am J Surg Pathol 37 496-505
- [3] Hattori S(2013)Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers Am J Clin Pathol 140 329-340
- [4] Tanikawa K(2014)Clinicopathological significance of “subtypes with stem-cell feature” in combined hepatocellular-cholangiocarcinoma Liver Int 35 1024-1035
- [5] Takenaka M(2015)Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress Hepat Oncol 2 255-273
- [6] Nakayama M(2006)Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma Surg Today 36 892-897
- [7] Ikeda H(2002)Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors Cancer 94 2040-2046
- [8] Harada K(1949)Combined liver cell and bile duct carcinoma Am J Pathol 25 647-655
- [9] Sato Y(2002)Comparing combined hepatocellular-cholangiocarcinoma and cholangiocarcinoma: a clinicopathological study Hepatogastroenterology 49 1487-1490
- [10] Sasaki M(2003)Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases Jpn J Clin Oncol 33 283-287